Australia Legal Cannabis MarketAustralia Legal Cannabis Market By Source (Hemp (Hemp CBD Oil, Supplements and Industrial Hemp) and Marijuana (Flower, Oil and Tinctures)), By Derivative (CBD (Cannabidiol), THC (Tetrahydrocannabinol) and Others), By Application (Medical (Chronic Pain, Cancer, Anxiety, Arthritis, Epilepsy, PTSD and Others), Recreational (Legalized in ACT and Restricted elsewhere) and Industrial), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Published date: March 2026
Report ID: 180498
Number of Pages: 205
Format:

Fact Checked

Cite this Research

Table of Content
- 1. Research Methodology and Data Source
  - 1.1. Methodology/Research Approach
  - 1.2. Market Size Estimation
  - 1.3. Market Breakdown and Data Triangulation
  - 1.4. Data Sources
  - 1.5. Secondary Sources
  - 1.6. Primary Sources
- 2. Executive Summary
  - 2.1. Taxonomy
  - 2.2. Market Outlook
  - 2.3. Key Facts and Figures
  - 2.4. Major Players in Australia Legal Cannabis Market
- 3. Market Overview
  - 3.1. Industry Overview
  - 3.2. Segmental Overview
  - 3.3. Market Dynamics
    
    3.3.1. Drivers
    
    3.3.2. Restraints
    
    3.3.3. Opportunities
    
    3.3.4. Trends
  - 3.4. Regulatory Framework
  - 3.5. Opportunity Map Analysis
  - 3.6. Opportunity Orbits
  - 3.7. Market Investment Feasibility Index
  - 3.8. PESTLE Analysis
  - 3.9. PORTER’S Five Force Analysis
  - 3.10. Drivers & Restraints Impact Analysis
  - 3.11. Patient Journey Mapping
  - 3.12. Technological Landscape
  - 3.13. Product Life Cycle Analysis
  - 3.14. Value Chain Analysis
    
    3.14.1. List of Raw Material Suppliers
    
    3.14.2. List of Australia Legal Cannabis Manufacturers
    
    3.14.3. List of Dealer/Distributors
    
    3.14.4. List of Potential Customers
  - 3.15. Cost Structure Analysis
- 4. Macro-economic Factors
- 5. Impact of Current Geopolitical Scenario
- 6. Australia Legal Cannabis Market Analysis and Forecast, By Source
  - 6.1. Key Findings
  - 6.2. Australia Legal Cannabis Market Size Value (US$ Mn) Forecast, By Source, 2020-2035
    
    6.2.1. Hemp
    
    6.2.1.1. Hemp CBD Oil
    
    6.2.1.2. Supplements
    
    6.2.1.3. Industrial Hemp
    
    6.2.2. Marijuana
    
    6.2.2.1. Flower
    
    6.2.2.2. Oil
    
    6.2.2.3. Tinctures
  - 6.3. Australia Legal Cannabis Market Attractiveness Analysis, By Source
- 7. Australia Legal Cannabis Market Analysis and Forecast, By Derivative
  - 7.1. Key Findings
  - 7.2. Australia Legal Cannabis Market Size Value (US$ Mn) Forecast, By Derivative, 2020-2035
    
    7.2.1. CBD (Cannabidiol)
    
    7.2.2. THC (Tetrahydrocannabinol)
    
    7.2.3. Others
  - 7.3. Australia Legal Cannabis Market Attractiveness Analysis, By Derivative
- 8. Australia Legal Cannabis Market Analysis and Forecast, By Application
  - 8.1. Key Findings
  - 8.2. Australia Legal Cannabis Market Size Value (US$ Mn) Forecast, By Application, 2020-2035
    
    8.2.1. Medical
    
    8.2.1.1. Chronic Pain
    
    8.2.1.2. Cancer
    
    8.2.1.3. Anxiety
    
    8.2.1.4. Arthritis
    
    8.2.1.5. Epilepsy
    
    8.2.1.6. PTSD
    
    8.2.1.7. Others
    
    8.2.2. Recreational
    
    8.2.2.1. Legalized in ACT
    
    8.2.2.2. Restricted elsewhere
  - 8.2.3. Industrial
  - 8.3. Australia Legal Cannabis Market Attractiveness Analysis, By Application
- 9. Competitive Landscape & Company Profiles
  - 9.1. Market Competition Scenario Analysis, By Company
  - 9.2. Competitor Landscape
  - 9.3. Company Share Analysis
  - 9.4. Company Profiles
    
    9.4.1. Vitura Health
    
    9.4.1.1. Company Details
    
    9.4.1.2. Business Overview
    
    9.4.1.3. Product Portfolio
    
    9.4.1.4. Financial Insights
    
    9.4.1.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    9.4.1.6. SWOT Analysis
    
    9.4.1.7. Geographic Footprint
    
    9.4.2. Little Green Pharma
    
    9.4.2.1. Company Details
    
    9.4.2.2. Business Overview
    
    9.4.2.3. Product Portfolio
    
    9.4.2.4. Financial Insights
    
    9.4.2.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    9.4.2.6. SWOT Analysis
    
    9.4.2.7. Geographic Footprint
    
    9.4.3. Bioxyne
    
    9.4.3.1. Company Details
    
    9.4.3.2. Business Overview
    
    9.4.3.3. Product Portfolio
    
    9.4.3.4. Financial Insights
    
    9.4.3.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    9.4.3.6. SWOT Analysis
    
    9.4.3.7. Geographic Footprint
    
    9.4.4. Green Farmers
    
    9.4.4.1. Company Details
    
    9.4.4.2. Business Overview
    
    9.4.4.3. Product Portfolio
    
    9.4.4.4. Financial Insights
    
    9.4.4.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    9.4.4.6. SWOT Analysis
    
    9.4.4.7. Geographic Footprint
    
    9.4.5. ECS Botanics
    
    9.4.5.1. Company Details
    
    9.4.5.2. Business Overview
    
    9.4.5.3. Product Portfolio
    
    9.4.5.4. Financial Insights
    
    9.4.5.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    9.4.5.6. SWOT Analysis
    
    9.4.5.7. Geographic Footprint
    
    9.4.6. Tasmanian Botanics
    
    9.4.6.1. Company Details
    
    9.4.6.2. Business Overview
    
    9.4.6.3. Product Portfolio
    
    9.4.6.4. Financial Insights
    
    9.4.6.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    9.4.6.6. SWOT Analysis
    
    9.4.6.7. Geographic Footprint
    
    9.4.7. Cann Group
    
    9.4.7.1. Company Details
    
    9.4.7.2. Business Overview
    
    9.4.7.3. Product Portfolio
    
    9.4.7.4. Financial Insights
    
    9.4.7.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    9.4.7.6. SWOT Analysis
    
    9.4.7.7. Geographic Footprint
    
    9.4.8. Zelira
    
    9.4.8.1. Company Details
    
    9.4.8.2. Business Overview
    
    9.4.8.3. Product Portfolio
    
    9.4.8.4. Financial Insights
    
    9.4.8.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    9.4.8.6. SWOT Analysis
    
    9.4.8.7. Geographic Footprint
    
    9.4.9. AusCann
    
    9.4.9.1. Company Details
    
    9.4.9.2. Business Overview
    
    9.4.9.3. Product Portfolio
    
    9.4.9.4. Financial Insights
    
    9.4.9.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    9.4.9.6. SWOT Analysis
    
    9.4.9.7. Geographic Footprint
    
    9.4.10. Bod Science
    
    9.4.10.1. Company Details
    
    9.4.10.2. Business Overview
    
    9.4.10.3. Product Portfolio
    
    9.4.10.4. Financial Insights
    
    9.4.10.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    9.4.10.6. SWOT Analysis
    
    9.4.10.7. Geographic Footprint
    
    9.4.11. Althea Group
    
    9.4.11.1. Company Details
    
    9.4.11.2. Business Overview
    
    9.4.11.3. Product Portfolio
    
    9.4.11.4. Financial Insights
    
    9.4.11.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    9.4.11.6. SWOT Analysis
    
    9.4.11.7. Geographic Footprint
    
    9.4.12. Incannex Healthcare
    
    9.4.12.1. Company Details
    
    9.4.12.2. Business Overview
    
    9.4.12.3. Product Portfolio
    
    9.4.12.4. Financial Insights
    
    9.4.12.5. Key Developments (Investment & Expansion, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    9.4.12.6. SWOT Analysis
    
    9.4.12.7. Geographic Footprint
List of Tables
- Table 1: Australia Legal Cannabis Market Value (US$ Mn), By Source, 2020–2034
- Table 2: Australia Legal Cannabis Market Value (US$ Mn), By Hemp, 2020–2034
- Table 3: Australia Legal Cannabis Market Value (US$ Mn), By Marijuana, 2020–2034
- Table 4: Australia Legal Cannabis Market Value (US$ Mn), By Derivative, 2020–2034
- Table 5: Australia Legal Cannabis Market Value (US$ Mn), By Application, 2020–2034
- Table 6: Australia Legal Cannabis Market Value (US$ Mn), By Medical, 2020–2034
- Table 7: Australia Legal Cannabis Market Value (US$ Mn), By Recreational, 2020–2034
List of Figures
- Figure 1: Australia Legal Cannabis Market Value (US$ Mn), 2020-2035
- Figure 2: Australia Legal Cannabis Market Value Share (%) Analysis, By Source, 2025 & 2035
- Figure 3: Australia Legal Cannabis Market Value Share (%) Analysis, By Derivative, 2025 & 2035
- Figure 4: Australia Legal Cannabis Market Value Share (%) Analysis, By Application, 2025 & 2035
- Figure 5: Australia Legal Cannabis Market Value Share (%) Analysis, By Source, 2020, 2025 and 2035
- Figure 6: Australia Legal Cannabis Market Attractiveness Analysis, By Source
- Figure 7: Australia Legal Cannabis Market Value Share (%) Analysis, By Derivative, 2020, 2025 and 2035
- Figure 8: Australia Legal Cannabis Market Attractiveness Analysis, By Derivative
- Figure 9: Australia Legal Cannabis Market Value Share (%) Analysis, By Application, 2020, 2025 and 2035
- Figure 10: Australia Legal Cannabis Market Attractiveness Analysis, By Application
- Vitura Health Limited (Dominant digital health and distribution platform)
- Little Green Pharma (LGP)
- Bioxyne
- Green Farmers (Biortica Agrimed)
- ECS Botanics
- Tasmanian Botanics
- Cann Group
- Zelira Therapeutics
- AusCann Group Holdings Ltd
- Bod Science
- Althea Group
- Incannex Healthcare